ScoreWhy is Sudarshan Pharma Industries Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.77 times
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.77 times
2
Healthy long term growth as Operating profit has grown by an annual rate 47.89%
3
Flat results in Jun 26
- INTEREST(9M) At Rs 22.02 cr has Grown at 35.09%
4
With ROCE of 10.8, it has a Attractive valuation with a 2.8 Enterprise value to Capital Employed
- Over the past year, while the stock has generated a return of 17.82%, its profits have risen by 36% ; the PEG ratio of the company is 1.2
5
Consistent Returns over the last 3 years
- Along with generating 17.82% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sudarshan Pharma should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sudarshan Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sudarshan Pharma
19.89%
0.35
50.75%
Sensex
-4.55%
-0.32
13.42%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
28.10%
EBIT Growth (5y)
47.89%
EBIT to Interest (avg)
2.17
Debt to EBITDA (avg)
5.40
Net Debt to Equity (avg)
1.83
Sales to Capital Employed (avg)
1.53
Tax Ratio
23.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.92%
ROCE (avg)
10.59%
ROE (avg)
15.03%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
38
Industry P/E
0
Price to Book Value
6.20
EV to EBIT
24.01
EV to EBITDA
22.17
EV to Capital Employed
2.84
EV to Sales
1.70
PEG Ratio
1.22
Dividend Yield
NA
ROCE (Latest)
10.83%
ROE (Latest)
15.03%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(9M)
At Rs 563.35 cr has Grown at 33.33%
PAT(9M)
At Rs 20.95 cr has Grown at 34.59%
-4What is not working for the Company
INTEREST(9M)
At Rs 22.02 cr has Grown at 35.09%
Loading Valuation Snapshot...
Here's what is working for Sudarshan Pharma
Net Sales - Latest six months
At Rs 395.34 cr has Grown at 28.84%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 16.59 cr has Grown at 30.77%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Sudarshan Pharma
Interest - Latest six months
At Rs 15.74 cr has Grown at 28.81%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
